|
FY2026
12 months to Mar 28, 2026
|
FY2025
12 months to Mar 29, 2025
|
FY2024
12 months to Mar 30, 2024
|
FY2023
12 months to Apr 1, 2023
|
FY2022
12 months to Apr 2, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Selling and Marketing Expense | |||||
| General and Administrative Expense | |||||
| Total selling, general and administrative | |||||
| Intangible Asset, Including Goodwill, Impairment Loss | |||||
| Other Cost and Expense, Operating | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense | |||||
| Other income, net | |||||
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Basic net (loss) income per share | |||||
| Net income (loss) per share | |||||
| Diluted | |||||
| Weighted-average shares of common stock outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...